Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL2400792

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Functional
Reversal of CGRP-induced dilation of human intracranial arterial rings
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Functional
Organism Homo sapiens
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery.
Chaturvedula PV, Mercer SE, Pin SS, Thalody G, Xu C, Conway CM, Keavy D, Signor L, Cantor GH, Mathias N, Moench P, Denton R, Macci R, Schartman R, Whiterock V, Davis C, Macor JE, Dubowchik GM.
Bioorg Med Chem Lett (2013) 23 : 3157 -3161
PubMed 23632269 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
EC50 1 9.06 9.06

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL2397415 ZAVEGEPANT 4.0 1 9.06

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL2397415 ZAVEGEPANT EC50 = 0.88 nM 9.06